Literature DB >> 19917596

Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.

Denise A Hien1, Huiping Jiang, Aimee N C Campbell, Mei-Chen Hu, Gloria M Miele, Lisa R Cohen, Gregory S Brigham, Carrie Capstick, Agatha Kulaga, James Robinson, Lourdes Suarez-Morales, Edward V Nunes.   

Abstract

OBJECTIVE: The purpose of the analysis was to examine the temporal course of improvement in symptoms of posttraumatic stress disorder (PTSD) and substance use disorder among women in outpatient substance abuse treatment.
METHOD: Participants were 353 women randomly assigned to 12 sessions of either trauma-focused or health education group treatment. PTSD and substance use assessments were conducted during treatment and posttreatment at 1 week and after 3, 6, and 12 months. A continuous Markov model was fit on four defined response categories (nonresponse, substance use response, PTSD response, or global response [improvement in both PTSD and substance use]) to investigate the temporal association between improvement in PTSD and substance use symptom severity during the study's treatment phase. A generalized linear model was applied to test this relationship over the follow-up period.
RESULTS: Subjects exhibiting nonresponse, substance use response, or global response tended to maintain original classification; subjects exhibiting PTSD response were significantly more likely to transition to global response over time, indicating maintained PTSD improvement was associated with subsequent substance use improvement. Trauma-focused treatment was significantly more effective than health education in achieving substance use improvement, but only among those who were heavy substance users at baseline and had achieved significant PTSD reductions.
CONCLUSIONS: PTSD severity reductions were more likely to be associated with substance use improvement, with minimal evidence of substance use symptom reduction improving PTSD symptoms. Results support the self-medication model of coping with PTSD symptoms and an empirical basis for integrated interventions for improved substance use outcomes in patients with severe symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19917596      PMCID: PMC2806486          DOI: 10.1176/appi.ajp.2009.09091261

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

1.  Symptom improvement in co-occurring PTSD and alcohol dependence.

Authors:  Sudie E Back; Kathleen T Brady; Susan C Sonne; Marcia L Verduin
Journal:  J Nerv Ment Dis       Date:  2006-09       Impact factor: 2.254

2.  Investigations of causal pathways between PTSD and drug use disorders.

Authors:  H D Chilcoat; N Breslau
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

3.  Multi-state models and diabetic retinopathy.

Authors:  G Marshall; R H Jones
Journal:  Stat Med       Date:  1995-09-30       Impact factor: 2.373

4.  Reasons for substance use in schizophrenia.

Authors:  J Addington; V Duchak
Journal:  Acta Psychiatr Scand       Date:  1997-11       Impact factor: 6.392

Review 5.  The development of a Clinician-Administered PTSD Scale.

Authors:  D D Blake; F W Weathers; L M Nagy; D G Kaloupek; F D Gusman; D S Charney; T M Keane
Journal:  J Trauma Stress       Date:  1995-01

6.  Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report.

Authors:  D F Klein; D C Ross
Journal:  Neuropsychopharmacology       Date:  1993-05       Impact factor: 7.853

7.  Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.

Authors:  E V Nunes; F M Quitkin; S J Donovan; D Deliyannides; K Ocepek-Welikson; T Koenig; R Brady; P J McGrath; G Woody
Journal:  Arch Gen Psychiatry       Date:  1998-02

8.  Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

Authors:  L Dixon; G Haas; P J Weiden; J Sweeney; A J Frances
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

9.  A new measure of substance abuse treatment. Initial studies of the treatment services review.

Authors:  A T McLellan; A I Alterman; J Cacciola; D Metzger; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1992-02       Impact factor: 2.254

10.  Subjective experiences related to alcohol use among schizophrenics.

Authors:  D L Noordsy; R E Drake; G B Teague; F C Osher; S C Hurlbut; M S Beaudett; T S Paskus
Journal:  J Nerv Ment Dis       Date:  1991-07       Impact factor: 2.254

View more
  115 in total

1.  The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study.

Authors:  Denise A Hien; Aimee N C Campbell; Lesia M Ruglass; Mei-Chen Hu; Therese Killeen
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.

Authors:  Nicole R Nugent; Michelle A Lally; Larry Brown; Valerie S Knopik; John E McGeary
Journal:  AIDS Behav       Date:  2012-11

3.  Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?

Authors:  Edward V Nunes; Samuel Ball; Robert Booth; Gregory Brigham; Donald A Calsyn; Kathleen Carroll; Daniel J Feaster; Denise Hien; Robert L Hubbard; Walter Ling; Nancy M Petry; John Rotrosen; Jeffrey Selzer; Maxine Stitzer; Susan Tross; Paul Wakim; Theresa Winhusen; George Woody
Journal:  J Subst Abuse Treat       Date:  2010-06

4.  Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence.

Authors:  Ajay Manhapra; Elina Stefanovics; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

5.  Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder.

Authors:  Elina A Stefanovics; Robert A Rosenheck; Karen M Jones; Grant Huang; John H Krystal
Journal:  Psychiatr Q       Date:  2018-03

6.  Web-based alcohol intervention for veterans: PTSD, combat exposure, and alcohol outcomes.

Authors:  Deborah J Brief; Marika Solhan; Denis Rybin; Justin L Enggasser; Amy Rubin; Monica Roy; Eric Helmuth; Amy Schreiner; Meagan Heilman; Lisa Vittorio; David Rosenbloom; Terence M Keane
Journal:  Psychol Trauma       Date:  2017-06-01

7.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

8.  Psychological distress among victimized women on probation and parole: A latent class analysis.

Authors:  Seana Golder; Malitta Engstrom; Martin T Hall; George E Higgins; T K Logan
Journal:  Am J Orthopsychiatry       Date:  2015-04-27

9.  Intimate partner violence outcomes in women with PTSD and substance use: a secondary analysis of NIDA Clinical Trials Network "Women and Trauma" Multi-site Study.

Authors:  Lisa R Cohen; Craig Field; Aimee N C Campbell; Denise A Hien
Journal:  Addict Behav       Date:  2013-03-21       Impact factor: 3.913

10.  Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.

Authors:  Amber M Jarnecke; Nicholas P Allan; Christal L Badour; Julianne C Flanagan; Therese K Killeen; Sudie E Back
Journal:  Addict Behav       Date:  2018-10-16       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.